When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Anti-obesity medication - Wikipedia

    en.wikipedia.org/wiki/Anti-obesity_medication

    Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of the human body , weight regulation, by: reducing appetite and consequently energy intake , increasing energy expenditure , redirecting nutrients from adipose to lean ...

  3. Category:Anti-obesity drugs - Wikipedia

    en.wikipedia.org/wiki/Category:Anti-obesity_drugs

    This page was last edited on 1 December 2023, at 23:34 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.

  4. Anti-Obesity Day - Wikipedia

    en.wikipedia.org/wiki/Anti-Obesity_Day

    Anti-Obesity Day (AOD) is observed in various parts of the world on November 26, with several healthcare organizations and leading Media primarily in India and the Gulf Cooperation Council (GCC) countries marking the day with activities to highlight how obesity is a public health hazard.

  5. Management of obesity - Wikipedia

    en.wikipedia.org/wiki/Management_of_obesity

    Several anti-obesity medications are currently approved by the FDA for long term use. [54] [55] [56] Semaglutide (Wegovy) is currently approved by the FDA for long-term use, being associated with a 6-12% loss in body weight compared to placebo. [57]

  6. Category:Combination anti-obesity drugs - Wikipedia

    en.wikipedia.org/wiki/Category:Combination_anti...

    This page was last edited on 1 December 2023, at 23:33 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.

  7. Obesity medicine - Wikipedia

    en.wikipedia.org/wiki/Obesity_medicine

    Obesity medicine is a field of medicine dedicated to the comprehensive treatment of patients with obesity. Obesity medicine takes into account the multi-factorial etiology of obesity in which behavior, development, environment, epigenetic , genetic , nutrition , physiology , and psychosocial contributors all play a role. [ 1 ]

  8. S-309309 - Wikipedia

    en.wikipedia.org/wiki/S-309309

    S-309309 is an experimental MGAT2 inhibitor developed as an anti-obesity drug by the Japanese company Shionogi. [ 1 ] [ 2 ] Phase II trial results are expected in late 2023. [ 3 ]

  9. Denatonium acetate - Wikipedia

    en.wikipedia.org/wiki/Denatonium_acetate

    Denatonium acetate (ARD-101) is an experimental anti-obesity drug that is a prodrug of the bitter compound denatonium, which is thought to be an agonist of the bitter-sensing type 2 taste receptors (TAS2R). It is hoped to activate the TAS2R receptors in the gut. [1] [2] It is tested in healthy adults [3] and people with Prader-Willi syndrome. [4]